Learning Objectives
Upon completion of this activity, participants should be able to:
- Clarify the disease burden imposed by untreated or undertreated anemia in patients with CKD, including in racially diverse patients
- Correlate the pathophysiology of anemia in CKD with viable therapeutic targets
- Identify appropriate candidates for emerging CKD-related anemia treatments among patients on or not on dialysis based on efficacy and safety data from recent clinical trials